Incyte Corp. Stock
Price
Target price
€58.52
€58.52
1.160%
0.68
1.160%
€81.98
04.07.25 / Tradegate
WKN: 896133 / Symbol: INCY / Name: Incyte / Stock / Biotechnology & Medical Research / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Incyte Corp. is only available for our menbers.
Not a member yet? Sign up for free!
Not a member yet? Sign up for free!
Financial data and news for Incyte
sharewise wants to provide you with the best news and tools for Incyte, so we directly link to the best financial data sources.
Financials
News
Incyte Stock: FDA Approval Boosts Cancer Drug Portfolio
Incyte Corporation has secured a significant regulatory milestone as the US Food and Drug Administration approved Monjuvi for treating patients with relapsed or refractory follicular lymphoma. The
Incyte Stock: Breakthrough Drug Shows Promise
Incyte Corporation is poised for significant market growth following positive results from two pivotal Phase 3 trials for Povorcitinib, its oral JAK1 inhibitor targeting Hidradenitis suppurativa
Why Incyte Stock Was Tanking This Week
A less-than-encouraging clinical trial for an investigative medicine was the news driving down Incyte (NASDAQ: INCY) stock over the past few days. The gloom this produced was pushing the biotech's
